One of the most important things to focus on this November during Lung Cancer Awareness Month is educating yourself about this disease and some of the related illnesses, like mesothelioma, which is often confused with lung cancer. Lung cancer is the number one cause of cancer deaths for men and...
Read More
June is Cancer Immunotherapy Awareness Month. Innovative treatments like immunotherapies are available through clinical trials and help expand mesothelioma patients’ options....
Read Post
A new bill called the Regulatory Accountability Act could prevent future attempts to ban asbestos. The bill was passed by the House of Representatives in January and now the...
Read Post
Two major pharmaceutical companies are teaming up to treat malignant pleural mesothelioma. Aduro Biotech and Merck are collaborating on an upcoming clinical trial testing CRS-207...
Read Post
A new study revealed that individuals who are exposed to asbestos earlier in their career are at a higher risk of developing pleural mesothelioma.The study published in the BMJ...
Read Post
A potential pleural mesothelioma treatment has received Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA). Receiving HUD designation may...
Read Post
A recent Centers for Disease Control (CDC) study unveiled that the state of Maine has the highest rate of asbestos-related deaths. Every year in the United States approximately...
Read Post
A few weeks ago Jenna Campagna and I had the privilege of sitting down with members of the support staff at the Mesothelioma Treatment Center in Houston, Texas. The Mesothelioma...
Read Post
A new phase 2 study is using a combination of immunotherapies to treat malignant pleural mesothelioma. In this trial, researchers are testing the safety and efficacy of two...
Read Post
Recently, NAPA Auto Parts and Genuine Parts Corp. were found liable in an asbestos-related death of a heavy equipment operator. The trial lasted for more than 12 weeks and found...
Read Post
A recent study published in The Lancet Oncology has revealed that the immunotherapy drug pembrolizumab may be an effective 2nd line treatment for mesothelioma. Pembrolizumab is...
Read Post